Updated for 2026
CNPLE women's health questions for Canadian nurse practitioners
CNPLE-aligned women's health practice questions spanning reproductive care, gynaecological presentations, contraception, prenatal care within NP scope, cancer screening, and menopause management — all framed within the Canadian NP competency model.
Provisional specifications
NurseNest CNPLE preparation materials are based on published Canadian nurse practitioner competency frameworks and currently available regulatory guidance. Final CNPLE specifications, item formats, timing, and scoring methods may change once officially released by CCRNR. Always verify current requirements at ccrnr.ca and with your provincial regulatory college.
Women's health scope for Canadian nurse practitioners
Canadian NPs in primary care settings manage a comprehensive range of women's health needs — from adolescent reproductive health through menopause and beyond. This includes contraception counselling and prescribing, routine gynaecological assessments, STI screening and treatment, prenatal care coordination, postnatal follow-up, and cancer screening programme delivery. The CNPLE tests these competencies within the autonomous NP practice model.
Women's health on the CNPLE is not a discrete section — it is integrated throughout lifespan care scenarios. A question presenting a 28-year-old seeking contraception counselling, a 34-year-old with abnormal uterine bleeding, a 42-year-old with perimenopausal symptoms, and a 58-year-old requiring osteoporosis screening all test women's health competencies in primary care NP context.
Contraception and reproductive health planning
Contraception counselling on the CNPLE tests decision-making, not catalogue memorisation. Given a patient's reproductive goals, medical history, and preferences, the NP selects the most appropriate method and explains relevant advantages, limitations, and contraindications. Key clinical decision points include combined hormonal contraceptive contraindications (migraine with aura, uncontrolled hypertension, DVT/PE history, prolonged immobility), IUD candidacy in nulliparous patients, and emergency contraception timing and efficacy.
STI screening protocols — who to screen, which tests to order, how to interpret results, and how to treat common infections including chlamydia, gonorrhoea, syphilis, and BV within Canadian NP prescriptive scope — appear in reproductive health scenarios. SOGC and PHAC guidelines provide the evidence framework that Canadian NPs are expected to apply.
Cancer screening and preventive gynaecology
Cervical cancer screening in Canada has shifted to primary HPV testing in most provinces — CNPLE-aligned preparation covers the transition from Pap smear to HPV-based screening, result interpretation, colposcopy referral thresholds, and HPV vaccination counselling within the national immunisation schedule. Breast cancer screening involves understanding provincial mammography programme eligibility, risk stratification for early or more intensive surveillance, and BRCA mutation counselling at the primary care level.
Abnormal uterine bleeding — one of the most common presentations in women's health primary care — requires systematic assessment (structural vs. non-structural causes using the PALM-COEIN classification), appropriate investigation (endometrial biopsy thresholds, pelvic ultrasound indications), and management options within NP scope including hormonal regulation, referral for endometrial evaluation, and iron supplementation for associated anaemia.
Menopause and perimenopausal management
Perimenopause identification and symptom assessment are primary care NP competencies. CNPLE-aligned preparation covers vasomotor symptom severity assessment, the cardiovascular and bone health implications of oestrogen decline, and evidence-based decision-making around menopausal hormone therapy initiation — including which patients are appropriate candidates, which regimens to consider (oestrogen alone vs. combined, systemic vs. local), and when hormone therapy is contraindicated.
Non-hormonal management options for patients who cannot or choose not to use hormone therapy — SSRIs and SNRIs for vasomotor symptoms, gabapentin, clonidine, and vaginal lubricants and moisturisers for genitourinary syndrome — are part of the CNPLE competency picture. Osteoporosis prevention and FRAX-based fracture risk assessment in postmenopausal women, along with calcium and vitamin D supplementation counselling, complete the menopause management domain.
Frequently asked questions
- What women's health topics are on the CNPLE?
- CNPLE-aligned women's health content includes contraception counselling and initiation (combined oral contraceptives, progestin-only options, IUDs, barrier methods, emergency contraception), reproductive health management (STI screening and treatment, vaginal discharge, pelvic inflammatory disease), prenatal and postnatal care within NP scope, gynaecological presentations (abnormal uterine bleeding, dysmenorrhoea, pelvic pain), menopause management, and cancer screening (cervical, breast, ovarian risk factors).
- How much prenatal care content is on the CNPLE?
- Canadian NPs manage prenatal care independently within their scope in many practice settings. CNPLE-aligned prenatal content covers routine antenatal care structure, common first and second trimester complications (hyperemesis, threatened miscarriage, gestational hypertension), screening test interpretation (NIPT, integrated prenatal screening, glucose challenge test), and appropriate referral thresholds. Intrapartum management is generally outside primary care NP scope and is less likely to be tested.
- How does contraception counselling appear on the CNPLE?
- Contraception questions test NP decision-making: selecting the most appropriate method given the patient's history and preferences, identifying contraindications (combined hormonal contraceptives in migraine with aura, hypertension, or hypercoagulable states), managing common side effects, and providing evidence-based counselling. Canadian Medical Eligibility Criteria and the Society of Obstetricians and Gynaecologists of Canada guidelines frame the clinical evidence.
- Is menopause management tested on the CNPLE?
- Yes. Menopause management within Canadian NP scope is a relevant competency: identifying perimenopause, assessing symptom burden, initiating and managing menopausal hormone therapy (indications, contraindications, regimen selection), non-hormonal options for patients who cannot use hormone therapy, and osteoporosis prevention and screening in the postmenopausal period.